Letters to the Editor
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis
P. Triggianese1, A. D'antonio2, P. Conigliaro3, F. Buccisano4, G.L. Fonti5, M.S. Chimenti6, R. Perricone7
- Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy. triggianese@med.uniroma2.it
- Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
- Haematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
CER13553
2021 Vol.39, N°2 ,Suppl.129
PI 0180, PF 0181
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 33338003 [PubMed]
Received: 11/05/2020
Accepted : 08/06/2020
In Press: 02/12/2020
Published: 19/05/2021
